Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DurAVR™ THV System: European Early Feasibility Study

NCT06510855 is registered in ClinicalTrials.gov with Anteris Technologies Ltd. as lead sponsor.

NCT NCT06510855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06510855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DurAVR™ THV System: European Early Feasibility Study
Lead sponsor
Anteris Technologies Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 21, 2025
Completion date
August 31, 2031
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve calcification, aortic valve disease, aortic valve failure, severe aortic valve stenosis, symptomatic aortic stenosis